Register
Login:
Share:
Email Facebook Twitter

Member Info for inanaco


Premium Member

Member Since: Wed, 19th Oct 2011

Number of Share Chat Posts (all time): 23,012
Number of Share Chat Posts (last 30 days): 1,013

Last Posted: Today 18:23


Post Distribution over the last 30 days




Today 18:23


seems Yoda is the expert ... LOL
Today 18:04


it needs a deal done... or some magic from the Nucants ...
Today 18:01


LOL ... says it all .. thanks for you input .. interesting day again, i see IMM have a few big buys in there
Today 17:48


exactly ... but this is waht he posted and you can see why i pulled him up ...........TheOriginalYoda

Posts: 1,362

Off Topic

Opinion: No Opinion

Price: 0.36

View Thread (3)RE: YodaToday 07:38I wouldn't be overly concerned about the timing Lukee. It's going to happen, be assured of that.

The authorisation will be for an expanded phase 1 and 2 trial. It will include dose escalation. This is an unusual application as it includes far more than MHRA would usually receive in one go. It's in depth.

Some investors, and certainly the market, do not seem to have grasped the depth of the trial application. We will have authority to head straight into increased doses and Clinical stage 2 of the trial. I have had this confirmed by the company. We are applying for a "therapy in Oncology, not a vaccine". There lies a major difference.
Today 17:38


its ok Tosh has been busy again proving me wrong .. LOL


Sign up for Live Prices
Top Recommended
Hot Chat Topics
Top recommended posters in the last 30 days
Share Price SpacerBigGib559 
Share Price Spacerspantrout501 
Share Price SpacerMarty4212484 
Share Price SpacerK3VMC446 
Share Price Spacersharehead442 
Share Price Spacerseanhunter407 
Share Price Spacerrylidan360 
Share Price Spacerdaveycaferacer358 




Member Login

Forgotten your password?
Email:

Password:


Don't have an account? Click here to Register Free!


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.